Structure of molecule 156389

Molecule card · MolClass #156389

CC12CCC3C(CCc4cc(OCc5ccccc5)ccc34)C1CC(O)C2O

CC12CCC3C(CCc4cc(OCc5ccccc5)ccc34)C1CC(O)C2O: molecular structure, identifiers, source datasets and 21 saved model results in MolClass.

0 source records · 21 model builds with saved results

Explore classification models

Structure and identifiers

MolClass ID
156389
InChIKey
GDUPBUZZJUIEDX-UHFFFAOYSA-N
Canonical SMILES
OC1CC2C3CCC4=CC(OCC=5C=CC=CC5)=CC=C4C3CCC2(C)C1O
Standard InChI
InChI=1S/C25H30O3/c1-25-12-11-20-19-10-8-18(28-15-16-5-3-2-4-6-16)13-17(19)7-9-21(20)22(25)14-23(26)24(25)27/h2-6,8,10,13,20-24,26-27H,7,9,11-12,14-15H2,1H3
Stored Murcko scaffold
O(c1ccc2c(c1)CCC3C2CCC4CCCC43)Cc5ccccc5

Registry normalization: IMPORTED_CDK_2_12. A registry entry does not establish drug approval or clinical use.

Molecules with the same Murcko scaffold

Exact matches to the stored ring-and-linker framework. Sharing a scaffold does not by itself establish activity or applicability to a model.

No other molecules currently have this stored scaffold.

Calculated molecular properties

Stored descriptor calculations, not measured experimental values.

Hydrogen bond acceptors
2
CDK 2.12 · 2026-11-02
Hydrogen bond donors
2
CDK 2.12 · 2026-11-02
Rotatable bonds
3
CDK 2.12 · 2026-11-02
Topological polar surface area
49.69 Ų
CDK 2.12 · 2026-11-02
Molecular weight
378.505 g/mol
CDK 2.12 · 2026-11-02
XLogP
5.662
CDK 2.12 · 2026-11-02

Saved model predictions

Computational predictions, not experimental measurements or clinical guidance. Results depend on the model build; applicability indicates similarity to its training chemistry.

Yeast Bioactive Library Cross-Kingdom - msp_ce_emb

Ensemble · model #157 · build #247

non-active

Model confidence
87.6%
Applicability domain
Outside domain
Scaffold similarity
49.4%

Recorded

Yeast Bioactive Library Cross-Kingdom - msp_ce

Ensemble · model #156 · build #246

non-active

Model confidence
98.2%
Applicability domain
Outside domain
Scaffold similarity
47.7%

Recorded

Mitochondrial Fusion

Ensemble · model #19 · build #137

active

Model confidence
61.7%
Applicability domain
In domain
Scaffold similarity
59.5%

Recorded

Anti-fungal drug pump selectivity

Ensemble · model #18 · build #29

inactive

Model confidence
90.1%
Applicability domain
In domain
Scaffold similarity
55.9%

Recorded

Toxcicity

Ensemble · model #17 · build #28

no toxicity reported

Model confidence
56.9%
Applicability domain
In domain
Scaffold similarity
55.7%

Recorded

Molecule Aggregation

Ensemble · model #16 · build #27

Aggregator

Model confidence
50.4%
Applicability domain
Outside domain
Scaffold similarity
39.9%

Recorded

Metabolite Likeness

Ensemble · model #15 · build #26

HMDB

Model confidence
56.8%
Applicability domain
Outside domain
Scaffold similarity
49.8%

Recorded

Thrombin Model

Ensemble · model #14 · build #25

Active

Model confidence
59.1%
Applicability domain
Outside domain
Scaffold similarity
49.7%

Recorded

Molecule Autofluorescence

LibSVM · model #13 · build #152

Autofluorescence

Model confidence
100.0%
Applicability domain
Outside domain
Scaffold similarity
49.8%

Recorded

ActinPolymerization: inhibit actin polymerization in PIP2-stimulated Xenopus egg extracts

Ensemble · model #12 · build #23

actin+

Model confidence
52.6%
Applicability domain
Outside domain
Scaffold similarity
45.2%

Recorded

BetaCellTransdifferentiation: To identify compounds that cause differentiation of Endocrine cell populations

J48 · model #11 · build #157

betacelltrans-

Model confidence
72.7%
Applicability domain
Outside domain
Scaffold similarity
48.9%

Recorded

Cell Cycle Activation/Inhibition

NaiveBayes · model #10 · build #21

cellcycle-

Model confidence
62.7%
Applicability domain
In domain
Scaffold similarity
50.7%

Recorded

HSP90 PPI Inhibition: qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction

Ensemble · model #9 · build #20

Hsp90_ppi-

Model confidence
77.2%
Applicability domain
Outside domain
Scaffold similarity
44.4%

Recorded

Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum

LibSVM · model #8 · build #159

inhibitor

Model confidence
100.0%
Applicability domain
In domain
Scaffold similarity
50.4%

Recorded

Blood Brain Barrier

RandomForest · model #7 · build #151

BBB+

Model confidence
60.2%
Applicability domain
Outside domain
Scaffold similarity
39.1%

Recorded

Derivation and validation of toxicophores for mutagenicity prediction

RandomForest · model #6 · build #15

nonmutagen

Model confidence
73.0%
Applicability domain
In domain
Scaffold similarity
51.2%

Recorded

Benchmark data set for in silico prediction of Ames mutagenicity

Ensemble2 · model #5 · build #134

none

Model confidence
93.7%
Applicability domain
In domain
Scaffold similarity
51.1%

Recorded

A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans

NaiveBayes · model #4 · build #14

none

Model confidence
98.6%
Applicability domain
In domain
Scaffold similarity
50.4%

Recorded

Cross-species discovery of syncretic drug combinations that potentiate the antifungal fluconazole

Ensemble · model #3 · build #17

Flu.Synergy

Model confidence
57.7%
Applicability domain
In domain
Scaffold similarity
50.4%

Recorded

ADME evaluation in drug discovery: Correlation of Caco-2 permeation with simple molecular properties

Ensemble · model #2 · build #244

app-

Model confidence
79.1%
Applicability domain
Outside domain
Scaffold similarity
42.3%

Recorded

Chemical genetics reveals a complex functional ground state of neural stem cells

Ensemble · model #1 · build #16

Mutual

Model confidence
50.9%
Applicability domain
In domain
Scaffold similarity
50.4%

Recorded

Source datasets

Dataset registrations and identifiers stored in MolClass.

No dataset registrations recorded.